Methods, Models, Systems, And Apparatus For Identifying Target Sequences For Cas Enzymes Or Crispr-Cas Systems For Target Sequences And Conveying Results Thereof

Patent No. EP2931892 (titled "Methods, Models, Systems, And Apparatus For Identifying Target Sequences For Cas Enzymes Or Crispr-Cas Systems For Target Sequences And Conveying Results Thereof") was filed by Massachusetts Institute OF Technology on Dec 12, 2013. The application was issued on Sep 12, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MATHYS & SQUIREJun 12, 2019WILDING
SCHLICHJun 12, 2019SCHLICH
CRISPR THERAPEUTICSFeb 28, 2019VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2931892

MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Application Number
EP13812447A
Filing Date
Dec 12, 2013
Status
Revoked
May 21, 2021
Publication Date
Sep 12, 2018